Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogIn
Corporate Member Sponsored Resources
Presentations & Abstracts
ACCC Connect eLearning LogIn
Publications
Oncology Issues
Patient Assistance & Reimbursement Guide
Trending Now in Cancer Care
Business Case Studies for Hiring New Staff
Events
2026 ACCC Leadership Summit
Annual Meeting & Cancer Center Business Summit
Capitol Hill Day
National Oncology Conference
Oncology Reimbursement Meetings
Oncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy Priorities
Letters & Statements
Access, Payment & Reimbursement Reform
White Bagging & Brown Bagging
Advocacy Resources
Cancer Moonshot
Membership
Join | Renew
Who We Are
Membership Types & Benefits
Corporate Members
ACCC Member Portal FAQ
Member Directory
Partners
Oncology State Societies
Partner Organizations
CME
News
News Releases
Advocacy News Releases
Oncology News
About ACCC
Timeline / 50th Anniversary
2025 Impact Report
President's Theme
ACCC Innovator Awards
ACCC Fellows
Board of Trustees
ACCC Senior Staff
Cancer Type
Breast Cancer
Metastatic Breast Cancer
Gastrointestinal Cancer
Biliary Tract Cancer
Colorectal Cancer
Gastric Cancer
Liver Cancer
Genitourinary Cancer
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Ovarian Cancer
Head & Neck Cancer
Hematologic Malignancies
Acute Lymphocytic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Mantle Cell Lymphoma (MCL)
Multiple Myeloma (MM)
Myelodysplastic Syndromes (MDS)
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Sarcoma
Skin Cancer
Melanoma
Non-Melanoma Skin Cancers (NMSC)
Topics
Clinical Practice & Treatment
Cancer Diagnostics
Care Coordination
EHR Integration for Biomarker Testing
Quality Improvement Collaboration: Integration of Precision Medicine in Community Oncology
Treatment
Financial Navigation
FAN Boot Camp
Financial Advocacy Network (FAN) Resource Library
Patient Assistance & Reimbursement Guide
Prior Authorization
Health Equity & Access
3, 2, 1, Go! Practical Solutions for Addressing Cancer Care Disparities
Appalachian Community Cancer Alliance
Oncology Advanced Practitioners
Personalizing Care for Patients of All Backgrounds
Social Drivers of Health
Patient-Centered Care
Addressing Care Disparities for Veterans
Adolescent and Young Adult (AYA)
Care Action Plans for People with Cancer
Dermatologic Toxicities
Empowering Caregivers
Geriatric Oncology
Health Literacy
Nutrition
Oncology Pharmacy
Patient Navigation
Psychosocial Care in Oncology
Shared Decision-Making
Supportive Care
Survivorship Care
Practice Management & Operations
Cancer Program Fundamentals
Leadership Sustainment and Engagement Videos
Oncology Practice Transformation and Integration Center
Oncology Team Resiliency
Research
ACCC Community Oncology Research Institute (ACORI)
Technology & Innovation
Telehealth & Digital Medicine
ACCC Media Platforms
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Cancer Type
Breast Cancer
Metastatic Breast Cancer
Gastrointestinal Cancer
Biliary Tract Cancer
Colorectal Cancer
Gastric Cancer
Liver Cancer
Genitourinary Cancer
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Ovarian Cancer
Head & Neck Cancer
Hematologic Malignancies
Acute Lymphocytic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Mantle Cell Lymphoma (MCL)
Multiple Myeloma (MM)
Myelodysplastic Syndromes (MDS)
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Sarcoma
Skin Cancer
Melanoma
Non-Melanoma Skin Cancers (NMSC)
Topics
Clinical Practice & Treatment
Cancer Diagnostics
Care Coordination
EHR Integration for Biomarker Testing
Quality Improvement Collaboration: Integration of Precision Medicine in Community Oncology
Treatment
Financial Navigation
FAN Boot Camp
Financial Advocacy Network (FAN) Resource Library
Patient Assistance & Reimbursement Guide
Prior Authorization
Health Equity & Access
3, 2, 1, Go! Practical Solutions for Addressing Cancer Care Disparities
Appalachian Community Cancer Alliance
Oncology Advanced Practitioners
Personalizing Care for Patients of All Backgrounds
Social Drivers of Health
Patient-Centered Care
Addressing Care Disparities for Veterans
Adolescent and Young Adult (AYA)
Care Action Plans for People with Cancer
Dermatologic Toxicities
Empowering Caregivers
Geriatric Oncology
Health Literacy
Nutrition
Oncology Pharmacy
Patient Navigation
Psychosocial Care in Oncology
Shared Decision-Making
Supportive Care
Survivorship Care
Practice Management & Operations
Cancer Program Fundamentals
Leadership Sustainment and Engagement Videos
Oncology Practice Transformation and Integration Center
Oncology Team Resiliency
Research
ACCC Community Oncology Research Institute (ACORI)
Technology & Innovation
Telehealth & Digital Medicine
ACCC Media Platforms
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Education & Resources
Publications
Events
Policy & Advocacy
Membership
Partners
News
About ACCC
Home
/
Education And Resources
/
Cancer Types
/
Hematologic Malignancies
/
Measurable Residual Disease Testing
Hematologic Malignancies
Acute Myeloid Leukemia (AML)
Advancing Care for Patients with Myeloproliferative Neoplasms
Advancements in Treating Patients with Myelofibrosis and Strategies to Improve Care
Chronic Lymphocytic Leukemia (CLL)
Follicular Lymphoma
Measurable Residual Disease (MRD) Testing
Multidisciplinary Acute Lymphocytic Leukemia Care
Multiple Myeloma
Reframing the Conversation: Effective Practices for Diffuse Large B-cell Lymphoma
Relapsed/Refractory Mantle Cell Lymphoma
MEASURABLE RESIDUAL DISEASE (MRD) TESTING
In this Section
